Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Windtree Therapeutics Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 27 | 19 | −8 |
| Shares | 1.72M | 1.46M | −258.0K (−15.0%) |
| Value | $3.94M | $3.02M | −$926.1K (−23.5%) |
New holders (3)
Institutions that held Windtree Therapeutics Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 5,200 | $11.0K | 0.00% |
| Federated Hermes, Inc. | 51 | $1.00K | 0.00% |
| Morgan Stanley | 25 | $0 | 0.00% |
Sold out (11)
Institutions that held Windtree Therapeutics Inc at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Millennium Management LLC | 114,474 | $262.0K |
| PVG Asset Management Corp | 68,180 | $156.1K |
| Goldman Sachs Group Inc | 66,952 | $153.0K |
| Frontier Wealth Management LLC | 60,000 | $137.0K |
| Envestnet Asset Management Inc | 38,246 | $88.0K |
| Jane Street Group, LLC | 32,017 | $73.0K |
| Tower Research Capital LLC (TRC) | 26,991 | $62.0K |
| Citadel Advisors LLC | 12,984 | $30.0K |
| Moloney Securities Asset Management, LLC | 10,890 | $25.0K |
| Two Sigma Securities, LLC | 10,139 | $23.0K |
| Advisory Services Network, LLC | 2,000 | $5.00K |